Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.31%749.35B | -8.08%712.56B | -0.15%3.02T | -5.40%698.33B | 8.92%804.37B | -0.81%775.23B | 12.84%3.02T | 5.26%762.48B | 6.49%738.19B | 10.79%738.48B |
| Cost of revenue | 12.18%529.35B | -7.95%495.11B | -2.61%2.09T | -10.46%471.88B | 3.85%550.37B | -2.45%537.88B | 7.68%2.14T | 0.14%535.88B | 2.23%527.02B | 4.46%529.95B |
| Gross profit | -2.84%220B | -8.39%217.44B | 5.88%927.98B | 7.23%226.45B | 21.81%254B | 3.12%237.35B | 27.82%876.47B | 19.71%226.6B | 18.83%211.17B | 30.97%208.53B |
| Operating expense | -6.36%148.34B | 15.95%155.83B | 11.82%612.34B | 15.72%158.41B | 17.61%149.61B | 5.89%134.4B | 16.20%547.64B | 1.11%156.63B | 17.54%136.89B | 18.61%127.2B |
| Selling and administrative expenses | 7.21%147.75B | 6.31%145.37B | 10.84%597.01B | 0.69%137.81B | 12.39%150.3B | 7.84%136.73B | 12.36%538.62B | -1.30%141.24B | 17.00%136.86B | 12.71%133.73B |
| -General and administrative expense | 7.21%147.75B | 6.31%145.37B | 10.84%597.01B | 0.69%137.81B | 12.39%150.3B | 7.84%136.73B | 12.36%538.62B | -1.30%141.24B | 17.00%136.86B | 12.71%133.73B |
| Other operating expenses | -75.38%6.43B | 878.29%17.39B | 24.41%38.81B | 369.36%26.11B | 22.66%6.74B | 50.30%1.78B | 320.05%31.19B | 463.84%20.35B | 134.09%5.56B | 667.88%5.5B |
| Total other operating income | 5.98%5.83B | 68.51%6.93B | 5.85%23.47B | -0.43%5.5B | -38.18%7.43B | 288.02%4.11B | 43.17%22.17B | 160.51%4.96B | 91.71%5.53B | -0.82%12.03B |
| Operating profit | 5.33%71.66B | -40.15%61.62B | -4.01%315.64B | -8.41%68.04B | 28.36%104.39B | -0.29%102.95B | 53.38%328.83B | 103.53%69.97B | 21.28%74.28B | 56.45%81.33B |
| Net non-operating interest income (expenses) | 46.26%4.71B | -52.54%1.5B | 46.07%19.66B | 43.28%3.22B | 23.78%6.21B | 41.03%3.17B | -19.70%13.46B | 55.81%3.95B | -10.86%2.25B | 37.50%5.02B |
| Non-operating interest income | 38.81%7.92B | 21.34%5.69B | 40.57%26.31B | 25.32%5.7B | 25.67%7.89B | 42.33%4.69B | -0.25%18.71B | 76.02%5.37B | 41.00%4.55B | 39.68%6.28B |
| Non-operating interest expense | 29.14%3.2B | 175.56%4.18B | 26.48%6.64B | 7.78%2.48B | 33.17%1.67B | 45.12%1.52B | 163.04%5.25B | 174.42%1.43B | 226.52%2.3B | 49.11%1.26B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 7.18%76.37B | -40.52%63.12B | -2.04%335.3B | -6.89%71.26B | 28.10%110.61B | 0.59%106.12B | 48.08%342.29B | 100.25%73.92B | 20.01%76.53B | 55.21%86.35B |
| Income tax | 59.49%28.74B | -44.95%14.89B | -4.35%80.73B | 1.60%18.02B | 17.41%26.32B | -10.70%27.05B | 44.64%84.4B | 34.25%13.96B | 1.23%17.74B | 112.22%22.42B |
| Net income | -9.22%48.72B | -39.25%48.11B | -0.13%259.66B | -9.69%53.67B | 31.08%84.88B | 5.13%79.18B | 49.05%260B | 127.22%60.5B | 27.68%59.43B | 41.43%64.75B |
| Net income continuous operations | -9.22%48.72B | -39.25%48.11B | -0.13%259.66B | -9.69%53.67B | 31.08%84.88B | 5.13%79.18B | 49.05%260B | 127.22%60.5B | 27.68%59.43B | 41.43%64.75B |
| Noncontrolling interests | -111.67%-765M | 7.97%6.76B | 35.67%29.23B | 11.42%6.56B | 39.05%6.99B | 0.69%6.26B | 19.90%21.54B | 14.80%4.41B | 34.13%5.88B | 4.31%5.03B |
| Net income attributable to the company | 5.03%49.48B | -43.30%41.35B | -3.36%230.44B | -12.01%47.11B | 30.41%77.88B | 5.53%72.92B | 52.39%238.46B | 146.19%56.09B | 27.01%53.54B | 45.80%59.72B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 5.03%49.48B | -43.30%41.35B | -3.36%230.44B | -12.01%47.11B | 30.41%77.88B | 5.53%72.92B | 52.39%238.46B | 146.19%56.09B | 27.01%53.54B | 45.80%59.72B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 7.41%43.5 | -42.04%35.97 | -2.05%197.61 | -10.83%40.5 | 31.41%66.27 | 6.80%62.06 | 53.93%201.74 | 148.15%47.72 | 28.12%45.42 | 47.37%50.43 |
| Diluted earnings per share | 7.41%43.5 | -42.04%35.97 | -2.05%197.61 | -10.83%40.5 | 31.41%66.27 | 6.80%62.06 | 53.93%201.74 | 149.46%47.72 | 28.12%45.42 | 47.37%50.43 |
| Dividend per share | 0 | 0 | 4.17%50 | 0 | 4.17%25 | 0 | 9.09%48 | 9.09%24 | 0 | 9.09%24 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |